170 related articles for article (PubMed ID: 24943688)
1. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer.
Tas F; Karabulut S; Bilgin E; Tastekin D; Duranyildiz D
Tumour Biol; 2014 Sep; 35(9):9303-9. PubMed ID: 24943688
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer.
Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
Tumour Biol; 2014 Apr; 35(4):3125-32. PubMed ID: 24254307
[TBL] [Abstract][Full Text] [Related]
3. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
[TBL] [Abstract][Full Text] [Related]
4. Serum IGF-1, IGFBP-3 levels and circulating tumor cells (CTCs) in early breast cancer patients.
Papadakis GZ; Mavroudis D; Georgoulias V; Souglakos J; Alegakis AK; Samonis G; Bagci U; Makrigiannakis A; Zoras O
Growth Horm IGF Res; 2017 Apr; 33():28-34. PubMed ID: 28258988
[TBL] [Abstract][Full Text] [Related]
5. Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer.
Holdaway IM; Mason BH; Lethaby AE; Singh V; Harvey VJ; Thompson PI; Evans BD
ANZ J Surg; 2003 Nov; 73(11):905-8. PubMed ID: 14616567
[TBL] [Abstract][Full Text] [Related]
6. Serum IGF-binding protein-6 and prostate specific antigen in breast cancer.
Kaulsay KK; Ng EH; Ji CY; Ho GH; Aw TC; Lee KO
Eur J Endocrinol; 1999 Feb; 140(2):164-8. PubMed ID: 10069662
[TBL] [Abstract][Full Text] [Related]
7. Levels of insulin-like growth factor I (IGF-I) and IGF binding proteins 2 and 3 in serial postoperative serum samples and risk of prostate cancer recurrence.
Yu H; Nicar MR; Shi R; Berkel HJ; Nam R; Trachtenberg J; Diamandis EP
Urology; 2001 Mar; 57(3):471-5. PubMed ID: 11248622
[TBL] [Abstract][Full Text] [Related]
8. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
Rinaldi S; Kaaks R; Zeleniuch-Jacquotte A; Arslan AA; Shore RE; Koenig KL; Dossus L; Riboli E; Stattin P; Lukanova A; Toniolo P
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):48-52. PubMed ID: 15668475
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of circulating IGF-I and IGFBP-3 as biomarkers for tumors in dogs.
Song DW; Ro WB; Sur JH; Seung BJ; Kang HM; Kim JW; Park SH; Park HM
J Vet Sci; 2021 Nov; 22(6):e77. PubMed ID: 34697923
[TBL] [Abstract][Full Text] [Related]
13. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
14. Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer.
Shariat SF; Kim J; Nguyen C; Wheeler TM; Lerner SP; Slawin KM
Urology; 2003 Feb; 61(2):359-64. PubMed ID: 12597948
[TBL] [Abstract][Full Text] [Related]
15. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.
Nam SY; Lee EJ; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 1997 May; 21(5):355-9. PubMed ID: 9152736
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancer.
Fürstenberger G; Senn E; Morant R; Bolliger B; Senn HJ
Breast; 2006 Feb; 15(1):64-8. PubMed ID: 15998587
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density.
Diorio C; Pollak M; Byrne C; Mâsse B; Hébert-Croteau N; Yaffe M; Coté G; Bérubé S; Morin C; Brisson J
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1065-73. PubMed ID: 15894654
[TBL] [Abstract][Full Text] [Related]
18. Serum insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in localized, metastasized prostate cancer and benign prostatic hyperplasia.
Aksoy Y; Aksoy H; Bakan E; Atmaca AF; Akçay F
Urol Int; 2004; 72(1):62-5. PubMed ID: 14730168
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I, insulin-like growth factor binding protein 3, and atrial fibrillation in the elderly.
Duron E; Vidal JS; Funalot B; Brunel N; Viollet C; Seux ML; Treluyer JM; Epelbaum J; Bouc YL; Hanon O
J Gerontol A Biol Sci Med Sci; 2014 Aug; 69(8):1025-32. PubMed ID: 24368776
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function.
Paolisso G; Ammendola S; Del Buono A; Gambardella A; Riondino M; Tagliamonte MR; Rizzo MR; Carella C; Varricchio M
J Clin Endocrinol Metab; 1997 Jul; 82(7):2204-9. PubMed ID: 9215295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
